Key facts, as of
As of November 6, 2026, GE HealthCare (GEHC) trades at $82.38, up 11.1% over the past year. Its 52-week range runs from $58.75 to $89.77; the price is 8.2% below that high. It is 13.1% below its all-time high of $94.80, reached in February 2025. It sits 17.9% above its 200-day average of $69.85. Its 30-day volatility is 38.5% annualized, which we rate high risk. It has a trailing P/E of 17.4 and a dividend yield of 0.19%.
Cite: Portfolio Terminal, "GE HealthCare (GEHC) stock analysis", 2026-11-06. https://portfolio-terminal.com/analyse/gehc
Where it trades today
trading 76% of the way up its 52-week range
How the price has moved
How far it is from its record
GE HealthCare (GEHC) is 13.1% below its all-time high of $94.80, reached in February 2025.
The read, from its own figures
What its numbers say
- GEHC closes above its 50-day average ($69.32) while the 50-day is still under the 200-day ($69.85): a rebound inside a longer decline, not yet an uptrend.
- At $82.38, GEHC is 8.2% below its 1-year high of $89.77, set on January 8, 2026, and 40.2% above its 1-year low of $58.75 (April 29, 2026).
- Over the past month GEHC rose 28.3%, from $64.22 to $82.38.
- GEHC trades at 17.4x its last twelve months of earnings and 15.0x the next twelve months' estimate, so analysts expect earnings 16.2% higher.
- Its P/E is 49.8% below the 34.7x median of the 3 other medical devices companies we track (ABT, SYK, BSX).
- GEHC's 30-day volatility, 38.5% a year, works out to a typical daily move of about 2.4%.
- Yahoo Finance puts its beta at 0.77: over five years of monthly returns, GEHC moved about 0.77% for each 1% move of the S&P 500.
What would change the read
- The rebound holds while it closes above the 50-day average, $69.32 (−15.9%); it becomes an uptrend when the 50-day climbs 0.8% to cross the 200-day at $69.85.
- A close above $89.77 (+9.0%) would be a new 1-year high; below $58.75 (−28.7%), a new 1-year low.
How it is computed
- Prices are Yahoo Finance's daily candles for GEHC, the same ones the chart below draws; the P/E, forward P/E and beta are Yahoo Finance quote fields.
- The averages are simple means of the last 50 and 200 closes; the 1-year high and low are the highest high and lowest low of the last 252 sessions; the 30-day volatility is the standard deviation of the past month's daily returns, annualized with the square root of 252.
- Peers are the other companies Yahoo Finance files under medical devices among the assets we track, not a full industry screen; the median counts those with a positive P/E.
- Every sentence here is written by code from those figures, refreshed daily; nobody edits it for GEHC by hand. It describes what the price and the multiples have done, not what they will do, and it is not advice.
Sources
- Yahoo Finance quote and daily historyopen →
The candles, the averages' inputs and the quote fields used for GEHC. Last refresh: Nov 8, 2026, 10:53 PM UTC.
- How Portfolio Terminal computes its figuresopen →
The methodology page behind the analytics and their refresh cadence.
- Industry classification
Yahoo Finance's industry, as stored in our list of tracked assets: Medical Devices.
What GE HealthCare does
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis,…
What analysts expect
GEHC carries a buy consensus from 20 analysts, with an average price target of $87.85 versus $82.38 today (+6.6%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
GEHC generated $21.64B in trailing revenue (7.2% year over year), with a 10.0% net margin, and $1.83B of free cash flow, against $7.58B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $20.63B | $8.25B | $2.76B | $2.08B | $4.56 | $1.50B |
| 2024 | $19.67B | $8.21B | $2.63B | $1.99B | $4.37 | $1.55B |
| 2023 | $19.55B | $7.92B | $2.44B | $1.57B | $3.05 | $1.71B |
| 2022 | $18.34B | $7.18B | $2.52B | $1.92B | $4.63 | $1.80B |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
GEHC is in 18 of the 54 ETFs we track. It weighs most in XLV: 0.49% of the fund, holding #42 of 62.
How its figures compare with those peers
Companies in the same industry
GEHC beside the other companies Yahoo Finance files under medical devices among the assets we track (ABT, SYK, BSX, largest first).
GEHCyou are here$82.38$37.25B
ABTAbbott Laboratories$109.93$190.39B
SYKStryker Corporation$325.87$124.06B
BSXBoston Scientific$42.75$61.96BWhat the chart is saying
Back above its 50-day average, still under the long-term trend.
recovering- Price is 18.8% above its 50-day average and 17.9% above its 200-day.
- RSI at 72 is overbought: strong momentum, and stretched.
- The nearest ceiling is $86.28 (+4.7%), the nearest floor $76.48 (-7.2%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
How is GEHC valued right now?
GE HealthCare trades at 17.4 times its last twelve months of earnings and 15.0 times the next twelve months' estimate (Yahoo Finance, November 6, 2026). On the chart: back above its 50-day average, still under the long-term trend. Price is 18.8% above its 50-day average and 17.9% above its 200-day.
What is the risk level of GEHC?
Based on 30-day volatility of 38.5%, GEHC has HIGH risk. Its beta of 0.77 means it has swung less than the S&P 500 over the last five years.
Does GEHC pay dividends?
Yes, GE HealthCare has a dividend yield of 0.19%.
How far is GEHC from its all-time high?
GE HealthCare is 13.1% below its all-time high of $94.80, reached in February 2025.
Which ETFs hold GEHC?
18 of the 54 popular ETFs we track hold GE HealthCare. The largest weights: XLV (0.49%), VO (0.29%), RSP (0.21%), CNDX (0.14%) and QQQM (0.14%). Measured on each issuer's full holdings file, dated September 30 to October 18, 2026.
How much of VOO is GEHC?
0.04%, as of September 30, 2026: GEHC is holding #307 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $0.45 in GE HealthCare.
What is the analyst price target for GEHC?
The average analyst price target for GE HealthCare (GEHC) is $87.85 based on 20 analyst estimates, about 6.6% above the current price of $82.38. The published range runs from $75.00 to $100.00.
How much revenue does GEHC generate?
GE HealthCare reported $21.64B in trailing twelve-month revenue. Revenue growth is running at 7.2% year over year. Net margin sits at 10.0%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare GEHC with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.